ClinicalTrials.Veeva

Menu

Study of Surgery in Patients With Idiopathic Macular Hole

P

Peking University

Status and phase

Unknown
Phase 4

Conditions

Surgery
Idiopathic Macular Hole

Treatments

Procedure: ILM peeling surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT02905409
ILMIMH-CHINA

Details and patient eligibility

About

The purpose of this study is to determine the effects of two different internal limiting membrane peeling with distinct diameters after macular hole surgery on anatomical closure grades.

Full description

The purpose of this study is to investigate two distinct diameter of internal limiting membrane peeling on anatomical outcomes of macular hole surgery with different preoperative idiopathic macular hole.

Enrollment

228 estimated patients

Sex

All

Ages

50 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with IMH
  • patients signed the ICF
  • patients with course of IMH less than 3 years

Exclusion criteria

  • patients with hyper myopia
  • patients with traumatic macular hole
  • accompanied or secondary of other fundus disease
  • open or reopen after receiving MH surgery
  • patients with retinal detachment
  • received vitrectomy due to other diseases
  • glaucoma cannot be controled by medication
  • patients with other retinal or choroidal disease that may affect VA
  • poor patients compliance
  • poor condition that cannot undertake the surgery
  • dioptric media opacities which make it difficult to exam fundus or measure on OCT

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

228 participants in 2 patient groups

4PD diameter of ILM peeling in surgery
Active Comparator group
Description:
Patients were stratified according to the macular hole closure index(MHCI) measured by OCT into 3 subgroup (MHCI\<0.5, 0.5≤MHCI\<0.7, MHCI≥0.7 ). And then randomized into 2 different intervention groups. If randomized into 4PD (papillary diameter) group, patients were given 4PD diameter of ILM (internal limiting membrane) peeling in surgery.
Treatment:
Procedure: ILM peeling surgery
2PD diameter of ILM peeling in surgery
Experimental group
Description:
Patients were stratified according to the macular hole closure index(MHCI) measured by OCT into 3 subgroup (MHCI\<0.5, 0.5≤MHCI\<0.7, MHCI≥0.7 ). And then randomized into 2 different intervention groups. If randomized into 2PD (papillary diameter) group, patients were given 2PD diameter of ILM (internal limiting membrane) peeling in surgery.
Treatment:
Procedure: ILM peeling surgery

Trial contacts and locations

1

Loading...

Central trial contact

Mingwei Zhao, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems